WealthCollab’s Vertex Pharmaceuticals VRTX Stock Holding History

WealthCollab’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.96K	Hold	14	–	–	﹤0.01%	653
2026 Q1	$6.25K	Sell	14 -6	-30%	-$2.8K	﹤0.01%	635
2025 Q4	$9.07K	Buy	20 +6	+43%	+$2.59K	﹤0.01%	586
2025 Q3	$5.48K	Hold	14	–	–	﹤0.01%	661
2025 Q2	$6.23K	Hold	14	–	–	﹤0.01%	585
2025 Q1	$6.79K	Hold	14	–	–	﹤0.01%	551
2024 Q4	$5.64K	Hold	14	–	–	﹤0.01%	568
2024 Q3	$6.51K	Hold	14	–	–	﹤0.01%	556
2024 Q2	$6.56K	Hold	14	–	–	﹤0.01%	521
2024 Q1	$5.85K	Hold	14	–	–	﹤0.01%	549
2023 Q4	$5.7K	Buy	+14	New	+$5.17K	﹤0.01%	533

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

WealthCollab's VRTX Position: Q2 2026 in Review

WealthCollab held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 14 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

WealthCollab first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.07K in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

WealthCollab held 14 shares of Vertex Pharmaceuticals worth $6.96K as of Q2 2026.
WealthCollab left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #653 holding.
WealthCollab first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
WealthCollab's Vertex Pharmaceuticals position peaked at $9.07K in Q4 2025.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.